HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murohara, T. Articles by Yasue, H. Search for Related Content PubMed PubMed Citation Articles by Murohara, T. Articles by Yasue, H. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1601-1608, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Effects of sphingomyelinase and sphingosine on arterial vasomotor regulation

T Murohara, K Kugiyama, M Ohgushi, S Sugiyama, Y Ohta and H Yasue
Division of Cardiology, Kumamoto University School of Medicine, Japan.

The sphingomyelin pathway is an important signal transduction system regulating various cellular functions. However, little is known about the effect of sphingomyelin metabolites on vasomotor function. We examined the vascular effects of sphingomyelin, sphingosine, and sphingomyelinase (SPMase) in vitro. In pig coronary rings precontracted with prostaglandin F2 alpha, sphingosine and SPMase evoked initial contraction and subsequent gradual relaxation; however, sphingomyelin did not influence the tone. The initial contractions in response to either SPMase (40 microU/ml to 0.4 U/ml) or sphingosine (0.5-10 microM) treatment were abolished in rings denuded of endothelium. This initial contraction in response to sphingosine treatment was significantly attenuated by a cyclo-oxygenase inhibitor indomethacin, but not altered by either a nitric oxide synthase inhibitor, N omega-monomethyl-L- arginine (L-NMMA), a protein kinase C (PKC) inhibitor staurosporine, or superoxide dismutase (SOD, 100 U/ml). Incubation of coronary rings with sphingosine (10 microM) or SPMase (0.4 U/ml) for 120 min significantly attenuated subsequent endothelium-dependent relaxation in response to thrombin and A23187, but did not affect endothelium-independent relaxation in response to sodium nitroprusside. In contrast, sphingomyelin (10 microM) did not alter the endothelium-dependent relaxation. In conclusion, in the sphingomyelin pathway, sphingosine induces vasoconstriction in coronary arteries that seems to be mediated by the release of cyclooxygenase-sensitive vasoconstrictor prostanoids from the endothelium. Sphingosine also induced endothelial dysfunction characterized by impaired endothelium-dependent relaxation. Thus, the sphingomyelin pathway may be an important regulator of vascular function.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-H. Hsiao, P. D. Constable, G. W. Smith, and W. M. Haschek Effects of Exogenous Sphinganine, Sphingosine, and Sphingosine-1-Phosphate on Relaxation and Contraction of Porcine Thoracic Aortic and Pulmonary Arterial Rings Toxicol. Sci., July 1, 2005; 86(1): 194 - 199. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF]

				P. D. Constable, G. W. Smith, G. E. Rottinghaus, M. E. Tumbleson, and W. M. Haschek Fumonisin-induced blockade of ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2034 - H2044. [Abstract] [Full Text] [PDF]

				D. X. Zhang, A.-P. Zou, and P.-L. Li Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H605 - H612. [Abstract] [Full Text] [PDF]

				D. X. Zhang, F.-X. Yi, A.-P. Zou, and P.-L. Li Role of ceramide in TNF-alpha -induced impairment of endothelium-dependent vasorelaxation in coronary arteries Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1785 - H1794. [Abstract] [Full Text] [PDF]

				T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF]

				D. English, J. G.N. Garcia, and D.N. Brindley Platelet-released phospholipids link haemostasis and angiogenesis Cardiovasc Res, February 16, 2001; 49(3): 588 - 599. [Abstract] [Full Text] [PDF]

				H. Doi, K. Kugiyama, M. Ohgushi, S. Sugiyama, T. Matsumura, Y. Ohta, H. Oka, N. Ogata, A. Hirata, Y. Yamamoto, et al. Membrane Active Lipids in Remnant Lipoproteins Cause Impairment of Endothelium-Dependent Vasorelaxation Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1918 - 1924. [Abstract] [Full Text] [PDF]

				L. Kleine, G. Liu, N. Leblanc, and R. L. Hebert Bradykinin stimulates ceramide production by activating specific BK-B1 receptor in rat small artery Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H175 - H183. [Abstract] [Full Text] [PDF]

				D. X. Zhang, A.-P. Zou, and P.-L. Li Ceramide Reduces Endothelium-Dependent Vasodilation by Increasing Superoxide Production in Small Bovine Coronary Arteries Circ. Res., April 27, 2001; 88(8): 824 - 831. [Abstract] [Full Text] [PDF]